SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-03-001087
Filing Date
2003-02-14
Accepted
2003-02-14 08:23:03
Documents
1
Period of Report
2003-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION i1665.htm 5 55947
  Complete submission text file 0001209191-03-001087.txt   57818
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Subject) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 5 | Act: 34 | File No.: 000-23736 | Film No.: 03562510
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GUILFORD PHARMACEUTICALS INC 6611 TIBUTARY ST. BALTIMORE MD 21224
Business Address 6611 TRIBUTARY STREET C/O GUILFORD PHARMACEUTICALS INC BALTIMORE MD 21224 4106316300
JORDAN ANDREW R (Reporting) CIK: 0001206350 (see all company filings)